Literature DB >> 15616302

Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli.

Jesse Deere1, Pat Iversen, Bruce L Geller.   

Abstract

Phosphorodiamidate morpholino oligomers (PMOs) are synthetic DNA analogs that inhibit gene expression in a sequence-dependent manner. PMOs of various lengths (7 to 20 bases) were tested for inhibition of luciferase expression in Escherichia coli. Shorter PMOs generally inhibited luciferase greater than longer PMOs. Conversely, in bacterial cell-free protein synthesis reactions, longer PMOs inhibited equally or more than shorter PMOs. Overlapping, isometric (10-base) PMOs complementary to the region around the start codon of luciferase inhibited to different extents in bacterial cell-free protein expression reactions. Including the anti-start codon in PMOs was not required for maximal inhibition. PMOs targeted to 5' nontranslated or 3' coding regions within luciferase mRNA did not inhibit, except for one PMO targeted to the ribosome-binding site. Inhibition of luciferase expression correlated negatively with the predicted secondary structure of mRNA regions targeted by PMO but did not correlate with C+G content of targeted regions. The effects of PMO length and position were corroborated by using PMOs (6 to 20 bases) targeted to acpP, a gene required for viability. Because inhibition by PMOs of approximately 11 bases was unexpected based on previous results in eukaryotes, we tested an 11-base PMO in HeLa cells and reticulocyte cell-free protein synthesis reactions. The 11-base PMO significantly inhibited luciferase expression in HeLa cells, although less than did a 20-base PMO. In reticulocyte cell-free reactions, there was a trend toward more inhibition with longer PMOs. These studies indicate that strategies for designing PMOs are substantially different for prokaryotic than eukaryotic targets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616302      PMCID: PMC538888          DOI: 10.1128/AAC.49.1.249-255.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Concepts to automate the theoretical design of effective antisense oligonucleotides.

Authors:  R K Far; W Nedbal; G Sczakiel
Journal:  Bioinformatics       Date:  2001-11       Impact factor: 6.937

2.  Antisense and sensibility.

Authors:  Alan Dove
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

3.  Mfold web server for nucleic acid folding and hybridization prediction.

Authors:  Michael Zuker
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Mutants of Escherichia coli permeable to actinomycin.

Authors:  M Sekiguchi; S Iida
Journal:  Proc Natl Acad Sci U S A       Date:  1967-12       Impact factor: 11.205

5.  Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc.

Authors:  R M Hudziak; J Summerton; D D Weller; P L Iversen
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-06

6.  Bactericidal antisense effects of peptide-PNA conjugates.

Authors:  L Good; S K Awasthi; R Dryselius; O Larsson; P E Nielsen
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

7.  Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3' end of 16S rRNA.

Authors:  K Jayaraman; K McParland; P Miller; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

8.  Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages.

Authors:  C J Marcus-Sekura; A M Woerner; K Shinozuka; G Zon; G V Quinnan
Journal:  Nucleic Acids Res       Date:  1987-07-24       Impact factor: 16.971

9.  Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.

Authors:  B L Geller; J D Deere; D A Stein; A D Kroeker; H M Moulton; P L Iversen
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli.

Authors:  Rikard Dryselius; Satish Kumar Aswasti; Gunaratna K Rajarao; Peter E Nielsen; Liam Good
Journal:  Oligonucleotides       Date:  2003
View more
  25 in total

1.  Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Authors:  Lucas D Tilley; Orion S Hine; Jill A Kellogg; Jed N Hassinger; Dwight D Weller; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

3.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  (99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.

Authors:  Ling Chen; Yi Wang; Dengfeng Cheng; Xinrong Liu; Shuping Dou; Guozheng Liu; Donald J Hnatowich; Mary Rusckowski
Journal:  Bioorg Med Chem       Date:  2013-08-28       Impact factor: 3.641

5.  Inhibition of Pseudomonas aeruginosa by Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers.

Authors:  James J Howard; Carolyn R Sturge; Dina A Moustafa; Seth M Daly; Kimberly R Marshall-Batty; Christina F Felder; Danniel Zamora; Marium Yabe-Gill; Maria Labandeira-Rey; Stacey M Bailey; Michael Wong; Joanna B Goldberg; Bruce L Geller; David E Greenberg
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Authors:  Rekha G Panchal; Bruce L Geller; Brett Mellbye; Douglas Lane; Patrick L Iversen; Sina Bavari
Journal:  Nucleic Acid Ther       Date:  2012-09-14       Impact factor: 5.486

7.  Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5.

Authors:  Raman Bahal; Nicole Ali McNeer; Danith H Ly; W Mark Saltzman; Peter M Glazer
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

8.  Morpholino oligomers tested in vitro, in biofilm and in vivo against multidrug-resistant Klebsiella pneumoniae.

Authors:  Bruce L Geller; Lixin Li; Fabian Martinez; Erin Sully; Carolyn R Sturge; Seth M Daly; Christine Pybus; David E Greenberg
Journal:  J Antimicrob Chemother       Date:  2018-06-01       Impact factor: 5.790

9.  Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo.

Authors:  Brett L Mellbye; Susan E Puckett; Luke D Tilley; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

10.  Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.

Authors:  Georgi M Mitev; Brett L Mellbye; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2009-07-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.